Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 25 | 0 |
| Shares | 1.25M | 1.20K | 1.21M | −41.3K (−3.3%) |
| Value | $3.05M | $2.00K | $2.71M | −$339.6K (−11.1%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 1,636 | $3.68K | 0.00% |
| UBS Group AG | 881 | $1.98K | 0.00% |
| Bank of America Corp | 105 | $236 | 0.00% |
| Citadel Advisors LLC | 64 | $144 | 0.00% |
Sold out (4)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 37,438 | $91.7K |
| XTX Topco Ltd | 13,041 | $31.9K |
| Two Sigma Investments, LP | 12,986 | $31.8K |
| Wells Fargo & Company | 87 | $213 |
Not filed for Q2 2024 yet (1)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cutler Group LP | 1,200 | $2.00K |